205 related articles for article (PubMed ID: 17638192)
1. Ganciclovir-resistant cytomegalovirus disease in heart transplant recipients: the dilemma of donor-positive/recipient-negative serostatus.
Avery RK
Clin Infect Dis; 2007 Aug; 45(4):448-9. PubMed ID: 17638192
[No Abstract] [Full Text] [Related]
2. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient.
García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR
Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients.
Li F; Kenyon KW; Kirby KA; Fishbein DP; Boeckh M; Limaye AP
Clin Infect Dis; 2007 Aug; 45(4):439-47. PubMed ID: 17638191
[TBL] [Abstract][Full Text] [Related]
4. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
Mabilangan C; Preiksaitis JK; Cervera C;
Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus prevention and long-term recipient and graft survival in pediatric heart transplant recipients.
Snydman DR; Kistler KD; Ulsh P; Morris J
Transplantation; 2010 Dec; 90(12):1432-8. PubMed ID: 21076378
[TBL] [Abstract][Full Text] [Related]
6. Impact of cytomegalovirus match on survival after cardiac and lung transplantation.
Bonatti H; Tabarelli W; Ruttmann E; Kafka R; Larcher C; Höfer D; Klaus A; Laufer G; Geltner C; Margreiter R; Müller L; Antretter H
Am Surg; 2004 Aug; 70(8):710-4. PubMed ID: 15328806
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus disease in renal transplant recipients: a single-center experience.
Basri N; Abdullah KA; Shaheen FA
Exp Clin Transplant; 2007 Jun; 5(1):601-3. PubMed ID: 17617050
[TBL] [Abstract][Full Text] [Related]
8. Preemptive therapy for cytomegalovirus infections and the development of resistance to ganciclovir.
Kroes AC; Kalpoe JS
J Infect Dis; 2002 Sep; 186(5):724-5; author reply 725-6. PubMed ID: 12195366
[No Abstract] [Full Text] [Related]
9. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
10. Ganciclovir prophylaxis for CMV disease infrequently associated with viral resistance.
AIDS Patient Care; 1995 Dec; 9(6):308. PubMed ID: 11361450
[No Abstract] [Full Text] [Related]
11. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
Puius YA; Snydman DR
Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
[TBL] [Abstract][Full Text] [Related]
12. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
[TBL] [Abstract][Full Text] [Related]
13. Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
Meylan PR; Pascual M
Clin Infect Dis; 2006 Oct; 43(7):881-3. PubMed ID: 16941369
[No Abstract] [Full Text] [Related]
14. Outcomes among pediatric heart transplant recipients.
Gajarski RJ; Rosenblatt HM; Denfield SW; Schowengerdt KO; Price JK; Towbin JA
Tex Heart Inst J; 1997; 24(2):97-104. PubMed ID: 9205982
[TBL] [Abstract][Full Text] [Related]
15. The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients.
Ozaki KS; Câmara NO; Nogueira E; Pereira MG; Granato C; Melaragno C; Camargo LF; Pacheco-Silva A
Clin Transplant; 2007; 21(5):675-80. PubMed ID: 17845644
[TBL] [Abstract][Full Text] [Related]
16. Ganciclovir resistance in a heart transplant recipient infected by cytomegalovirus.
Manso JV; Lambert JL; Oña M; de la Iglesia JL; Iglesias J
Int J Cardiol; 1999 Sep; 71(1):97-8. PubMed ID: 10522573
[No Abstract] [Full Text] [Related]
17. Drug resistance in cytomegalovirus: current knowledge and implications for patient management.
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 12 Suppl 1():S1-22. PubMed ID: 8680897
[No Abstract] [Full Text] [Related]
18. Experience of cytomegalovirus infection in heart-lung transplant recipients.
Smyth RL; Scott JP; Higenbottam TW; Wreghitt TG; Stewart S; Fradet G; Clelland CA; Wallwork J
Transplant Proc; 1990 Aug; 22(4):1820-1. PubMed ID: 2167539
[No Abstract] [Full Text] [Related]
19. Cytomegalovirus (CMV) resistance to antivirals.
Drew WL; Paya CV; Emery V
Am J Transplant; 2001 Nov; 1(4):307-12. PubMed ID: 12099372
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P
Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
